SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-012747
Filing Date
2020-05-11
Accepted
2020-05-11 21:44:48
Documents
1
Period of Report
2020-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9319
  Complete submission text file 0000899243-20-012747.txt   10863
Mailing Address ALLERGAN 5 GIRALDA FARMS MADISON NJ 07940
Business Address
WALSH MATTHEW M (Reporting) CIK: 0001269428 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36867 | Film No.: 20866893

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Issuer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences